Covered recipient · General Payments record
KELSEY ANNE SMITH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$569.08
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.34 | 9 |
| Education | $49.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $49.99 | 1 |
| Acerta Pharma LLC | $33.37 | 2 |
| Amgen Inc. | $31.20 | 2 |
| Lilly USA, LLC | $28.72 | 1 |
| CooperSurgical, Inc. | $25.00 | 1 |
| Janssen Biotech, Inc. | $22.79 | 1 |
| Genentech USA, Inc. | $19.78 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.34 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117385519 | CMS |
| Amgen Inc. | $13.86 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117385521 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.74 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104608810 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.63 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105564942 | CMS |
| CooperSurgical, Inc. | $25.00 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150792573 | CMS |
| Genentech USA, Inc. | $19.78 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133167921 | CMS |
| Incyte Corporation | $49.99 | 11/07/2024 | Education | Undisputed | 01/23/2026 | 1141288130 | CMS |
| Janssen Biotech, Inc. | $22.79 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078327620 | CMS |
| Lilly USA, LLC | $28.72 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135794374 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.48 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144984094 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.